Titan Pharmaceuticals Cash from Financing (TTM) Insights

Titan Pharmaceuticals Inc (TTNP)

6.97 -0.04 (-0.57%) USD | NASDAQ | Apr 24, 16:00

6.97 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 1996. Upgrade now.

Date	Value
December 31, 2023	10.00M
September 30, 2023	9.594M
June 30, 2023	0.00
March 31, 2023	0.003M
December 31, 2022	4.984M
September 30, 2022	4.984M
June 30, 2022	4.984M
March 31, 2022	4.981M
December 31, 2021	8.841M
September 30, 2021	14.75M
June 30, 2021	17.22M
March 31, 2021	18.72M
December 31, 2020	17.93M
September 30, 2020	20.10M
June 30, 2020	19.65M
March 31, 2020	18.72M
December 31, 2019	11.27M
September 30, 2019	7.712M
June 30, 2019	14.80M
March 31, 2019	14.22M
December 31, 2018	10.62M
September 30, 2018	5.816M
June 30, 2018	3.729M
March 31, 2018
December 31, 2017

Date	Value
September 30, 2017
June 30, 2017
March 31, 2017	0.027M
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015	-0.014M
September 30, 2015	9.578M
June 30, 2015	9.578M
March 31, 2015	9.541M
December 31, 2014	9.555M
September 30, 2014	4.888M
June 30, 2014	4.888M
March 31, 2014	2.425M
December 31, 2013	3.813M
September 30, 2013	2.564M
June 30, 2013	6.032M
March 31, 2013	13.45M
December 31, 2012	12.02M
September 30, 2012	13.34M
June 30, 2012	9.876M
March 31, 2012	17.16M
December 31, 2011	16.94M
September 30, 2011	11.67M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

Minimum

Jun 2023

20.10M

Maximum

Sep 2020

11.01M

Average

10.00M

Median

Dec 2023

Cash from Financing (TTM) Benchmarks